Forte Biosciences (FBRX) Other financing activities (2017 - 2025)

Forte Biosciences (FBRX) has 5 years of Other financing activities data on file, last reported at $475000.0 in Q3 2025.

• Other financing activities for Q3 2025 came in at $475000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $5.1 million (up 27.11% YoY), and the FY2025 annual result was $7.4 million, up 563.78% from the prior year.
• Other financing activities slipped to $475000.0 in Q3 2025 per FBRX's latest filing, from $4.6 million in the prior quarter.
• Over five years, Other financing activities peaked at $4.6 million in Q2 2025 and troughed at $22000.0 in Q3 2021.
• A 4-year average of $967500.0 and a median of $387500.0 in 2021 frame the typical range for Other financing activities.
• On a YoY basis, Other financing activities climbed as much as 1387.5% in 2022 and fell as far as 63.33% in 2022.
• A 4-year view of Other financing activities shows it stood at $40000.0 in 2021, then surged by 1387.5% to $595000.0 in 2022, then soared by 88.4% to $1.1 million in 2024, then plunged by 57.63% to $475000.0 in 2025.
• Business Quant data shows FBRX's Other financing activities at $475000.0 in Q3 2025, $4.6 million in Q2 2025, and $2.3 million in Q1 2025.